Laura Alder, Medical Oncology Deputy Director at Duke Center for Brain and Spine Metastasis, shared a post on LinkedIn:
“I’m honored to have been nominated to serve on the American Society of Clinical Oncology (ASCO) expert panel responsible for maintaining the Therapy for Stage IV Non-Small Cell Lung Cancer Living Guidelines.
Lung cancer care is evolving rapidly, and I’m excited to work alongside incredible colleagues to ensure clinicians have the most current, evidence-based guidance at their fingertips!”
Other articles featuring Laura Alder on OncoDaily.